# In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity

> **NCT04368897** · — · WITHDRAWN · sponsor: **Applied Biology, Inc.**

## Conditions studied

- SARS-CoV 2
- COVID
- COVID-19
- Androgenetic Alopecia
- Androgen Receptor Abnormal
- Androgen Deficiency

## Interventions

- **DIAGNOSTIC_TEST:** CAG length <22
- **DIAGNOSTIC_TEST:** CAG length >=22

## Key facts

- **NCT ID:** NCT04368897
- **Lead sponsor:** Applied Biology, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-05-01
- **Primary completion:** 2022-12-01
- **Final completion:** 2022-12-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Not able to recruit subjects
- **Last updated:** 2023-07-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04368897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04368897, "In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04368897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*